|
|
 |
 
The Changing Face of FSGS/MCD
Flash slide/audio
(ASN Renal Week Clinical Nephrology Conference Extract, October, 2009)
Radhakrishnan: How should we treat minimal change disease on initial presentation? How should we treat patients who are frequent relapsers? Those who are refractory to therapy? Should treatment be changed for the C1Q and IgM variants? How is adult MCD different from that in children? Cattran: What is the value of achieving partial remission in FSGS? Should initial treatment still be steroids, especially in older patients, or obese patients? If not, what might be alternatives for initial treatment? What do the other options include? Is cyclosporin the best? What about tacrolimus? MMF? Rituximab? Pirfenidone? Kopp: In treating FSGS, is pulse oral dexamethasone and alternative to daily steroids? What are the results with rituximab or adalimumab in treating FSGS? Is there a role for pirfenidone, for rosiglitazone, and for retinoids such as isotretinoin? What do the preliminary results show?
(more...)
|
 |
 |
 |
ANNA CE
(Article Free, $CE) |
ANNA CE (NNJ)
Target audience: Nurses. Article free, CE requires payment to
ANNA
via HDCN.
Quality of Life in Patients Undergoing Hemodialysis and Renal Transplantation A Meta-Analytic Review
(Vol 37/No. 1. Expires 2/20/2012)
Kandace Landreneau, PhD, RN, CCTC, Kathryn Lee, PhD, RN, FAAN, and Michael D. Landreneau, MD
1.3 hr
The Dual Vitamin D Pathways: Considerations for Adequate Supplementation
(Vol 37/No. 1. Expires 2/20/2012)
Susan C. Cronin, MS, RN
1.4 hr
Seeking Optimal Renal Replacement Therapy Delivery in Intensive Care Units
(Vol 37/No. 1. Expires 2/20/2012)
Marinka Kocjan, MN, RN, CNCC(C), and Fabrice P. Brunet, MD, FRCPC
1.3 hr
|
|
|
 |
ASN Renal Week 2009
now in MP3
|
AUDIOFILE
LIST (ASN Renal Week 2009)
(23 talks)
Sex and the Kidney
P. August, S.B. Ahmed, S.A. Karumanchi, and J.A. Miller
Multiple Myeloma
G.A. Herrera, P.M. Voorhees, F. Madore, J.A. Katzmann
Management of Hyponatremia
R.H. Stenrs, H.J. Adrogue, J.G. Verbalis
The Approaching Tidal Wave of Hypertension and Its Sequelae in the Young
B. Falkner, S.R. Daniels, J.T. Flynn, R-E. W. Kavey
The Kidney in End Stage Liver Disease
R.W. Schrier, T.A. Gonwa, A. Davenport, and P-Y. Fan
Renal Diseases of Children in Adults
M.E. Ferris, F. Hildebrandt, R.L. Chevalier, and S. Goldstein
|
 |
|
|
|
Hypertension, Cardiovascular:
Cell hypoxia and renal neurogenic HTN.
Dialysis, CKD:
Eplerenone good in CKD5D; Death risk vs. alk phos, FGF23; Aging vs. frailty, CKD progression; FGF23 and renal outcome in diabetic nephropathy; Fractional excretion of phosphorus to assess dietary compliance; Dietary protein intake and Pi balance; Once-daily niacin and Pi balance; Chewed vs. crushed lanthanum; Fermagate (Alpharen) as a Pi binder; Intestinal phosphate transporter and Pi balance; On-line HDF good for Pi; FGF23 and prediction of outcome, PTH control, progression; Parathyroidectomy with high intensity ultrasound; Variability of PTH estimation serially; TACE inhibition to treat secondary PTH; Cinacalcet pulse therapy; Farnesyl transferas inhibitors and vascular calcification; LVM reduction with cinacalcet.
Clinical Nephrology:
New genetic locus for autosomal dominant polycystic liver disease; Kidney ultrasound to Dx early PKD in kids; Salt intake worsens ADPKD; Tolvaptan trial in ADPKD.
Transplant:
Suboptimal MMF dosing bad; Belatacept good; Extended release MPS better than MMF; Carbon monoxide prevents kidney damage during warm ischemia time; Integrative approach to transplanting high-risk sensitized patients.
(more...)
|
|
 |
|
|
Sustaining a hemodialysis exercise program: a review
Bennett and colleagues reviews not only the potential benefits of a dialysis patient exercise program, but practical issues in setting up a sustainable program;
in the Jan/Feb issue of Seminars in Dialysis.
(more...) |
|
|
Posing the question again: does chronic uric acid nephropathy exist?
Orson Moe provides a very balanced review of this topic: "The association between hyperuricemia and chronic kidney disease is not
in doubt. It is the nature of the association that is under debate."
in the March issue of the J Am Soc Nephrol (JASN)
(more...) |
|
|
Review on pharmacokinetics and pharmacodynamics and the aging kidney
Aymanns and colleagues review drug dosing in the elderly from a variety of perspectives, including age-related decline in renal function;
in the March issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity
Kaul et al discuss HTLV1 and 2, the prevalence rates, and issues regarding donor screening in view of changes to the assay for these infections;
in the February issue of the Am J Transplant.
(more...) |
|
|
Sorbent augmented hemodialysis systems: are we there yet?
Winchester and Ronco review the new devices in preparation that will use sorbents for dialysis, including the wearable artificial kidney;
in the February issue of the J Am Soc Nephrol (JASN)
(more...) |
|
|
Novel B-cell therapeutic targets in transplantation and immune- mediated glomerular diseases
Vincenti, Cohen, and Appel discuss not only rituximab but other novel B-cell therapies and their efficacy against lupus, ANCA, IgA, FSGS, and other related conditions;
in the January issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
Role of rituximab therapy in glomerulonephritis
Jayne reviews rituximab efficacy in ANCA vasculitis, SLE, and membranous GN,
in the January issue of the J Am Soc Nephrol (CJASN)
(more...) |
|
|
Metabolic syndrome in solid organ transplantation
Sharif discusses pathophysiology, risk factors, effects on graft and patient survival, as well as implicated drugs and avoidance strategies;
in the January issue of the Am J Transplant.
(more...) |
|
|
The role of the mammalian target of rapamycin (mTOR) in renal disease
Lieberthal and Levine review how mTOR is involved in recovery from renal injury, diabetic nephropathy, cystic diseases of the kidney, and renal carcinoma;
in the December issue of the J Am Soc Nephrol (CJASN)
(more...) |
|
|
Cardiorenal syndrome in acute decompensated heart failure
Sarraf, Maoumi and Schrier review pathogenesis and various possible treatments,
in the December issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence
Thomas and Jaber look critically at the data for use of hemodiafiltration and other convective therapies in both acute and chronic situations;
in the Nov/Dec issue of Seminars in Dialysis.
(more...) |
|
|
Interstitial cystitis: an unsolved enigma
Moutzouris and Falagas review the diagnosis of IC, the role of specific and supportive therapies, and directions for future research,
in the November issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
MASTering Treg function to promote tolerance
Levings and Thomson discuss a paper by Noelle in which rejection of skin grafts was treated by activation of mast cells in a T-cell mediated process;
in the October issue of the Am J Transplant.
(more...) |
|
| 450+ |
|
 |
SUMMARIES of Recent Slide/Audio Symposia
in reverse chronological
order
|
 |
 |
Boots on the Ground: Do We Have Enough Personnel to Fight the Battle Against CKD? (Wish and Piraino)
|
|
|
Controversies in Vascular Access (Asif and Urbanes)
|
|
|
ASDIN: 5th Annual Scientific Meeting, February, 2009.
|
|
|
Nephrology Quiz and Questionnaire: Fluids and Electrolyte and Glomerular Disorders (Palmer and Pusey)
|
|
|
Primary Care in Nephrology: Preoperative Risk Assessment and Management of Glycemic Control (Golper and Mordes)
|
|
|
IgA Nephropathy: Time to Change Our Approach? (Feehally and Hogg)
|
|
|
Advances in CKD 2009 (various speakers)
|
|
|
CKD Care and Your Practice Culture: Improve Your Performance! (Maddux, Molony, Kliger, Blaser, et al)
|
|
|
The Sexual Life Cycle of Women with CKD (Yao, Hou, Kurella-Tamura)
|
|
|
Resistant Hypertension: A Challenge for the Nephrologist (Campese and Steigerwalt)
|
 |
|
New Frontiers in Phosphorus Homeostasis in CKD
(Quarles, Wolf)
|
|
|
Care of the Chronic Kidney Disease Patient
(Campbell, Berns, Batlle)
|
|
|
Managing CKD-MBD through the Disease Continuum
(Thadhani, Kestenbaum)
|
|
|
Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure
(Goldberg, Schrier, and Gheorghiade)
|
|
|
The Year in Nephrology: Hypertension and Metabolic Renal Syndrome (Griffin and Beddhu)
|
|
|
Nephrology Roundtable: Glucose Transport and Targets for Intervention
(De Zeeuw, Wright)
|
|
|
Acute Renal Replacement Therapy (Palevsky)
|
|
|
The ESA Controversy: The Role of Intravenous Iron
(Ganz, Agarwal, Besarab)
|
|
|
Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia
(Schmidt, Toto, Norris)
|
|
|
Gammopathies and the Kidney and Thrombotic Microangiopathy (Falk)
|
|
|
Ischemic Nephropathy: Diagnosis and Management (Textor)
|
|
|
Disorders of Calcium and Phosphorus Metabolism (Wolf)
|
|
FREE
 |
Managing Anemia in Chronic Kidney Disease: The Benefits to Patients (Schira)
|
|
|
Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)
|
|
|
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases (Emmett and Radhakrishnan)
|
|
|
Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease (Textor and Dworkin)
|
|
FREE
|
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD) (Schmidt and Senft)
|
|
|
New Insights, Treatments, and Management Strategies for ADPKD (Chapman and Calvet)
|
|
FREE
|
Stabilizing Hemoglobin Levels: What's New in IV Iron and Anemia Management? (Fishbane, VanBuskirk, Larson)
|
|
|
Novel Therapeutics for Fluid and Electrolyte Disorders (Verbalis and Palmer)
|
|
|
DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
|
|
|
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
|
|
FREE
|
New Perspectives on the Progression of Coronary Artery Calcification
and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
|
|
|
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
|
|
|
Nephrolithiasis (Worcester and Lieske)
|
|
|
The Genetics of FSGS (Hildebrandt and Kaskel)
|
|
|
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
|
|
|
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
|
|
|
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
|
|
|
ASDIN Annual Meeting 2008
|
|
|
RPA Annual Meeting 2008
|
|
|
Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
|
|
|
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
|
|
|
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
|
|
|
Pre-ESRD and Mineral Metabolism (Martin and Moe)
|
|
|
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
|
|
|
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout
(Terkeltaub, Rich, Feig)
|
|
|
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
|
|
|
The Aging Kidney (Fliser and Aronoff)
|
|
|
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions
(London, Langman, Ketteler)
|
|
|
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction
(Burnett, Fowler, Gheorghiade)
|
|
|
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
|
|
|
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis
(Persson, Knopp, Perazella)
|
|
|
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
|
|
|
The Cystic Diseases (Bennett)
|
|
|
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
|
|
|
Critical Care Nephrology (Murray)
|
|
FREE
|
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
|
|
|
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
|
|
|
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
|
|
FREE
|
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient
(Easom, Juergensen, Amerling)
|
|
|
Sudden Death in Hemodialysis Patients: Epidemiology
|
|
|
Diabetes and Non-insulin Management in CKD
|
|
|
Obesity and Outcomes in Dialysis Patients
|
|
|
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
|
|
FREE
|
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
|
|
FREE
|
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
|
|
|
Cocaine and Chronic Kidney Injury
|
|
|
Proton Pump Inhibitors and the Kidney: Critical Review
|
|
|
Characteristics of the Long-Term Peritoneal Dialysis Patient
|
|
|
Prospects and Challenges for a Staphylococcal Vaccine
|
|
|
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
|
|
|
Overview of Catheter Lock Solutions
|
|
|
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
|
|
|
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
|
|
|
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
|
|
|
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
|
|
|
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
|
|
|
Bone and Mineral Metabolism in CKD: Medical Crossfire
|
|
|
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
|
|
|
Fluid Dysregulation: Disturbances and Management
|
|
|
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
|
|
|
Inflammation in CKD: Biomarkers, Morbidity and Therapy
|
|
|
Managing CMV Infections in Transplantation
|
|
|
RRI Ninth International Conference on Dialysis, January, 2007. Part One
|
|
|
Disorders of Sodium Metabolism: Case Presentations
|
|
|
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
|
|
|
Transplant Biopsy
|
|
|
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
|
|
|
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
|
|
|
Lupus Nephritis: Defining and Treating Renal Flares
|
|
|
Secondary Hypertension, including Chronic Kidney Disease
|
|
|
New, Tri-Partite Approach to Anemia
|
|
|
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
|
|
|
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
|
|
|
Transplantation: Medical and Immunosuppressive Management
|
|
|
Using Technology to Improve the Quality of Care (target audience: technicians)
|
| more... |
|
|
Nocturnal dipping measurements unreliable
96